Abstract
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
Issue: Sep/Oct 2018 - Volume 22, Number 5
Page(s): 401-404
Abstract
Compounders engaged in making sterile preparations need to employ a quality assurance system of documented policies and procedures to attempt to reduce the possibility of contamination. The quality-assurance program will be monitored through the facility’s quality control system. Compounders should be aware of the requirements of each state they are licensed in as well as the inspection observations commonly noted in 483s issued by the U.S. Food and Drug Administration. In part 1 of this 2-part article, we discuss the currently evolving regulatory environment and why sterile compounding requires planning and monitoring to deliver quality compounds to patients. Part 2 will examine the United States Pharmacopeia’s discussion on the principles of quality assurance and quality control in sterile compounding.
Related Keywords
Related Categories
Related Articles from IJPC
| Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
|---|---|
|
Sep/Oct 2018
Pg. 401-404
|
|
|
Mar/Apr 2020
Pg. 92
|
|
|
May/Jun 2020
Pg. 180
|
|
|
Mar/Apr 2021
Pg. 115-124
|
|
|
Mar/Apr 2012
Pg. 146-150
|
|
|
Sep/Oct 2007
Pg. 404-410
|
|
|
Jul/Aug 2007
Pg. 302-305
|
|
|
Jul/Aug 2013
Pg. 283-288
|
|
|
Nov/Dec 2021
Pg. 491-496
|
|
|
Mar/Apr 2008
Pg. 136-144
|
|
|
Nov/Dec 2018
Pg. 475-478
|
|
|
May/Jun 2008
Pg. 216-229
|
|
|
May/Jun 2009
Pg. 234-238
|
|
|
Jan/Feb 2012
Pg. 6-10
|
|
|
Sep/Oct 2007
Pg. 400-403
|
|
|
May/Jun 2015
Pg. 215-221
|
|
|
Jul/Aug 2009
Pg. 322-329
|
|
|
Jan/Feb 2010
Pg. 60-64
|
|
|
Jul/Aug 2007
Pg. 314-323
|
|
|
Mar/Apr 2015
Pg. 121-124
|